NCOA3 and cancer: The patients classified as locally advanced cancer demonstrated higher expression of the target genes, demonstrating the influence of the assessed genes in cancer phenotypes with poorer prognoses, which has already been shown in the literature for SRC-1, SRC-3, and AR-V7 (Xu et al. 2009; Sobhani et al. 2021).